Yanyan Hou
Yanyan Hou has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Cuifang Hao
Center for Reproductive Medicine, Women and Children’s Hospital, Qingdao University, Qingdao, China
1 shared publication - Hailun Yan
Department of Civil and Environmental Engineering, Norwegian University of Science and Technology, Høgskoleringen 1, 7034 Trondheim, Norway
1 shared publication - Hongjie Zhang
Tianjin Key Laboratory of Modern Mechatronics Equipment Technology, School of Mechanical Engineering, Tiangong University, Tianjin 300387, China
1 shared publication Hongwei Jin
1 shared publication- Hui Liu
Department of Physiology Basic Medical College, Nanchang University Nanchang China
1 shared publication - Jian-Feng Xiang
Department of Human Genetics, Emory University School of Medicine, 615 Michael St, Atlanta, GA 30322, USA
1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by Elsevier in SSRN Electronic Journal
Three-Dimensional Defect Morphology Reconstruction Based on Spatial Magnetic Flux Leakage Field Measurements
Conventional MFL testing methods are limited in 3D defect reconstruction due to the loss of spatial magnetic field information. To address this issue, a spatial MFL-based 3D defect reconstruction framework is proposed. Coordinated XY scanning is employed to acquire high-density spatial MFL measurements, and a regression-based inversion model is developed to establish the mapping between multidimensional MFL responses and defect depth distributions. The estimated depth distribution is subsequently integrated with spatial coordinates to reconstruct 3D defect point clouds, followed by spatial filtering and nonuniform rational B-spline (NURBS) surface fitting to improve geometric continuity and suppress reconstruction noise. Experimental validation on 50 independent defect samples demonstrates that the proposed framework achieves accurate morphology reconstruction for defects with different geometric characteristics. Quantitatively, the framework constrains the maximum-depth mean absolute error (MAE) and volume relative error (VRE) to 0.08 ± 0.05 mm and 1.48% ± 0.91%, respectively, while achieving a high three-dimensional intersection over union (3D-IoU) of 0.93 ± 0.04. The reconstructed surfaces exhibit high consistency with theoretical defect profiles in both global geometric morphology and local contour characteristics. The proposed framework provides an effective solution for quantitative 3D defect reconstruction using spatial MFL measurements.
- 1 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessThree-Dimensional Defect Morphology Reconstruction Based on Spatial Magnetic Flux Leakage Field Measurements
Conventional MFL testing methods are limited in 3D defect reconstruction due to the loss of spatial magnetic field information. To address this issue, a spatial MFL-based 3D defect reconstruction framework is proposed. Coordinated XY scanning is employed to acquire high-density spatial MFL measurements, and a regression-based inversion model is developed to establish the mapping between multidimensional MFL responses and defect depth distributions. The estimated depth distribution is subsequently integrated with spatial coordinates to reconstruct 3D defect point clouds, followed by spatial filtering and nonuniform rational B-spline (NURBS) surface fitting to improve geometric continuity and suppress reconstruction noise. Experimental validation on 50 independent defect samples demonstrates that the proposed framework achieves accurate morphology reconstruction for defects with different geometric characteristics. Quantitatively, the framework constrains the maximum-depth mean absolute error (MAE) and volume relative error (VRE) to 0.08 ± 0.05 mm and 1.48% ± 0.91%, respectively, while achieving a high three-dimensional intersection over union (3D-IoU) of 0.93 ± 0.04. The reconstructed surfaces exhibit high consistency with theoretical defect profiles in both global geometric morphology and local contour characteristics. The proposed framework provides an effective solution for quantitative 3D defect reconstruction using spatial MFL measurements.
- Open Access
- 16 April 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (15) , e25301
Performance evaluation of CA242 by flow fluorescence assay
Carbohydrate antigen 24–2 (CA24–2) is usually used as a biomarker for the diagnosis of pancreatic cancer and colorectal cancer. Currentlly, a new quantitative assay kit for CA242 by flow fluorometry assay (FFA) was developed by Shanghai Tellgen Cooperation Co. Ltd. China. Therefore, we conducted the performance evaluation for it. According to the “Guiding principles on performance analysis of diagnostic reagents in vitro” and “American association of clinical laboratory standardization guidelines EP15-A2”, the accuracy, precision, linear range, reportable range, biological reference interval verification, carry-over contamination rate, anti-interference capability and cross reaction of the assay kit used in TESMI F3999-Luminex200 automatic immunoassay system were evaluated. In addition, the assay kit was performed in parallel to CanAg kit (CanAg Diagnostics Products Beijing Co., Ltd.) to analyze the correlation between the 2 kits. The bias of accuracy of the new assay kit was less than 12.5% and the coefficient of variations (CVs) of precision were all less than 10.0%. The linear range of CA242 concentration of the testing kit was between 3.46 U/ml and 434.76 U/ml and the reportable range was 6.00 to 535.13 U/ml. The CA242 reference interval 0.00 to 20.00 U/ml was suitable for use in laboratory. The carry-over contamination rate was −0.14%. Correlation analysis showed a satisfactory relevance and consistency (r = 0.982, P < .001) between the new assay kit and CanAg kit, with a regression equation Y = 1.0012X to 0.878 (R 2 = 0.9647, P < .001). No statistically significant difference between serum samples without interferences and samples containing lipemia, bilirubin and hemoglobin. And no cross reaction existed between the assay kit and the other tumor markers, such as carbohydrate antigen 125 (CA125), alpha-fetoprotein (AFP), and cytokeratin-19 soluble fragment (CYFRA21-1). The new CA242 quantitative assay kit possesses good detection performance when it is used in TESMI F3999-Luminex200 automatic immunoassay system, which can be used for the examination of CA242 in clinical practice.
- 16 April 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (15) , e25301
Open AccessPerformance evaluation of CA242 by flow fluorescence assay
Carbohydrate antigen 24–2 (CA24–2) is usually used as a biomarker for the diagnosis of pancreatic cancer and colorectal cancer. Currentlly, a new quantitative assay kit for CA242 by flow fluorometry assay (FFA) was developed by Shanghai Tellgen Cooperation Co. Ltd. China. Therefore, we conducted the performance evaluation for it. According to the “Guiding principles on performance analysis of diagnostic reagents in vitro” and “American association of clinical laboratory standardization guidelines EP15-A2”, the accuracy, precision, linear range, reportable range, biological reference interval verification, carry-over contamination rate, anti-interference capability and cross reaction of the assay kit used in TESMI F3999-Luminex200 automatic immunoassay system were evaluated. In addition, the assay kit was performed in parallel to CanAg kit (CanAg Diagnostics Products Beijing Co., Ltd.) to analyze the correlation between the 2 kits. The bias of accuracy of the new assay kit was less than 12.5% and the coefficient of variations (CVs) of precision were all less than 10.0%. The linear range of CA242 concentration of the testing kit was between 3.46 U/ml and 434.76 U/ml and the reportable range was 6.00 to 535.13 U/ml. The CA242 reference interval 0.00 to 20.00 U/ml was suitable for use in laboratory. The carry-over contamination rate was −0.14%. Correlation analysis showed a satisfactory relevance and consistency (r = 0.982, P < .001) between the new assay kit and CanAg kit, with a regression equation Y = 1.0012X to 0.878 (R 2 = 0.9647, P < .001). No statistically significant difference between serum samples without interferences and samples containing lipemia, bilirubin and hemoglobin. And no cross reaction existed between the assay kit and the other tumor markers, such as carbohydrate antigen 125 (CA125), alpha-fetoprotein (AFP), and cytokeratin-19 soluble fragment (CYFRA21-1). The new CA242 quantitative assay kit possesses good detection performance when it is used in TESMI F3999-Luminex200 automatic immunoassay system, which can be used for the examination of CA242 in clinical practice.
- Open Access
- 15 March 2021
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 41 (3)
XIST knockdown suppresses vascular smooth muscle cell proliferation and induces apoptosis by regulating miR-1264/WNT5A/β-catenin signaling in aneurysm
LncRNAs have been ascertained as vital modulators in abdominal aortic aneurysm (AAA) development. In this research, the function and molecular mechanisms of the lncRNA XIST in the evolution of vascular smooth muscle cells (VSMCs) were assessed. Results showed that XIST expression was increased but miR-1264 expression level was reduced in the serum of AAA patients. XIST depletion impeded HA-VSMCs’ ability to proliferate and stimulate apoptosis, while repressing miR-1264 expression through an unmediated interaction. Additionally, the influence of XIST knockdown on apoptosis and proliferation could be rescued by a miR-1264 inhibitor. Subsequent molecular investigations indicated that WNT5A was miR-1264's target, and XIST functioned as a ceRNA of miR-1264 to raise WNT5A expression. Further, a miR-1264 inhibitor stimulated the proliferation and suppressed the apoptosis of HA-VSMCs through the activation of WNT/β-catenin signaling. Taken together, XIST impeded the apoptosis and stimulated the proliferation of HA-VSMCs via the WNT/β-catenin signaling pathway through miR-1264, demonstrating XIST's underlying role in AAA.
- 15 March 2021
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 41 (3)
Open AccessXIST knockdown suppresses vascular smooth muscle cell proliferation and induces apoptosis by regulating miR-1264/WNT5A/β-catenin signaling in aneurysm
LncRNAs have been ascertained as vital modulators in abdominal aortic aneurysm (AAA) development. In this research, the function and molecular mechanisms of the lncRNA XIST in the evolution of vascular smooth muscle cells (VSMCs) were assessed. Results showed that XIST expression was increased but miR-1264 expression level was reduced in the serum of AAA patients. XIST depletion impeded HA-VSMCs’ ability to proliferate and stimulate apoptosis, while repressing miR-1264 expression through an unmediated interaction. Additionally, the influence of XIST knockdown on apoptosis and proliferation could be rescued by a miR-1264 inhibitor. Subsequent molecular investigations indicated that WNT5A was miR-1264's target, and XIST functioned as a ceRNA of miR-1264 to raise WNT5A expression. Further, a miR-1264 inhibitor stimulated the proliferation and suppressed the apoptosis of HA-VSMCs through the activation of WNT/β-catenin signaling. Taken together, XIST impeded the apoptosis and stimulated the proliferation of HA-VSMCs via the WNT/β-catenin signaling pathway through miR-1264, demonstrating XIST's underlying role in AAA.
- Open Access
- 13 January 2020
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 36 (5) , 363-370
Mesenchymal stem cells‐derived exosomes improve pregnancy outcome through inducing maternal tolerance to the allogeneic fetus in abortion‐prone mating mouse
Recurrent pregnancy loss (RPL) is three or more times of consecutive spontaneous loss of pregnancy. The underlying cause is complicated and the etiology of over 50% of RPL patients is unclear. In the present study, bone marrow mesenchymal stem cells were isolated from CBA/J female mice and exosomes were isolated from cell culture medium by ultracentrifugation. CBA/J female mice were paired with male DBA/2 to generate abortion prone mouse model, and CBA/J females paired with male BALB/c mice were used as control. Exosomes were injected through uterine horns into pregnant CBA/J mice on day 4.5 of gestation in abortion‐prone matting. On day 13.5 of pregnancy, abortion rates were calculated and the level of transforming growth factor‐β (TGF‐β), interleukin 10 (IL‐10), interferon g (IFN‐γ), and tumor necrosis factor a (TNF‐α) in CD4+ T cells and macrophages in deciduas were evaluated by flow cytometry. Exosomes injection improved the pregnancy outcomes in abortion prone mice. The IL‐4 and IL‐10 levels on CD4+ T cells were upregulated in the maternal–fetal interface; meanwhile, the TNF‐α and IFN‐γ levels on CD4+ T cells were reduced. The IL‐10 level was increased and IL‐12 was reduced on the monocytes that separated from deciduas. miR‐101 level was increased in the CD4+ T cells in the deciduas. In conclusion, the treatment of ESCs‐derived exosomes modulates T cells' function and macrophages activities in the maternal–fetal interface that resulted in a decreased embryo resorption rate, and provides a therapeutic potential to treat RPL.
- 13 January 2020
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 36 (5) , 363-370
Open AccessMesenchymal stem cells‐derived exosomes improve pregnancy outcome through inducing maternal tolerance to the allogeneic fetus in abortion‐prone mating mouse
Recurrent pregnancy loss (RPL) is three or more times of consecutive spontaneous loss of pregnancy. The underlying cause is complicated and the etiology of over 50% of RPL patients is unclear. In the present study, bone marrow mesenchymal stem cells were isolated from CBA/J female mice and exosomes were isolated from cell culture medium by ultracentrifugation. CBA/J female mice were paired with male DBA/2 to generate abortion prone mouse model, and CBA/J females paired with male BALB/c mice were used as control. Exosomes were injected through uterine horns into pregnant CBA/J mice on day 4.5 of gestation in abortion‐prone matting. On day 13.5 of pregnancy, abortion rates were calculated and the level of transforming growth factor‐β (TGF‐β), interleukin 10 (IL‐10), interferon g (IFN‐γ), and tumor necrosis factor a (TNF‐α) in CD4+ T cells and macrophages in deciduas were evaluated by flow cytometry. Exosomes injection improved the pregnancy outcomes in abortion prone mice. The IL‐4 and IL‐10 levels on CD4+ T cells were upregulated in the maternal–fetal interface; meanwhile, the TNF‐α and IFN‐γ levels on CD4+ T cells were reduced. The IL‐10 level was increased and IL‐12 was reduced on the monocytes that separated from deciduas. miR‐101 level was increased in the CD4+ T cells in the deciduas. In conclusion, the treatment of ESCs‐derived exosomes modulates T cells' function and macrophages activities in the maternal–fetal interface that resulted in a decreased embryo resorption rate, and provides a therapeutic potential to treat RPL.